EMA
approval
· 2019-03-01
New add-on treatment to insulin for treatment of certain patients with type 1 diabetes
Summary
EMA announces a new add-on treatment to insulin for certain patients with type 1 diabetes, expanding therapeutic options.
Upgrade for the full analysis, importance score, and drug timeline.